Vivesto Stock

Vivesto FCF Margin

Free Cash Flow Margin of Vivesto (VIVE.ST) as of Aug 10, 2026.

FCF Margin

0.00

Last updated:

Free Cash Flow Margin of Vivesto is 2026 0.00 . Free Cash Flow Margin of Vivesto was 2025 -7,960.00 % . It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Vivesto since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Vivesto with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Vivesto

All Key Metrics — Vivesto